[HTML] thelancet.comFull View

[HTML][HTML] Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia

Y Wada, M Maekawa, T Ohnishi, S Balan… - …, 2020 - thelancet.com
Background The pathophysiology of schizophrenia, a major psychiatric disorder, remains
elusive. In this study, the role of peroxisome proliferator-activated receptor (PPAR)/retinoid X …
被引用次数：22 相关文章

[引用][C] Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia

Y Wada, M Maekawa, T Ohnishi, S Balan, S Matsuoka… - eBioMedicine, 2020 - cir.nii.ac.jp
Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす …

Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia

Y Wada, M Maekawa, T Ohnishi, S Balan… - …, 2020 - tohoku.elsevierpure.com
Background: The pathophysiology of schizophrenia, a major psychiatric disorder, remains
elusive. In this study, the role of peroxisome proliferator-activated receptor (PPAR)/retinoid X …
[HTML] nih.gov

[HTML][HTML] Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia

Y Wada, M Maekawa, T Ohnishi, S Balan… - …, 2020 - ncbi.nlm.nih.gov
Background The pathophysiology of schizophrenia, a major psychiatric disorder, remains
elusive. In this study, the role of peroxisome proliferator-activated receptor (PPAR)/retinoid X …

Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia.

Y Wada, M Maekawa, T Ohnishi, S Balan… - Ebiomedicine, 2020 - europepmc.org
Background The pathophysiology of schizophrenia, a major psychiatric disorder, remains
elusive. In this study, the role of peroxisome proliferator-activated receptor (PPAR)/retinoid X …
[HTML] sciencedirect.com

[HTML][HTML] Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia

Y Wada, M Maekawa, T Ohnishi, S Balan, S Matsuoka… - eBioMedicine, 2020 - Elsevier
Background The pathophysiology of schizophrenia, a major psychiatric disorder, remains
elusive. In this study, the role of peroxisome proliferator-activated receptor (PPAR)/retinoid X …

Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia

Y Wada, M Maekawa, T Ohnishi, S Balan… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The pathophysiology of schizophrenia, a major psychiatric disorder, remains
elusive. In this study, the role of peroxisome proliferator-activated receptor (PPAR)/retinoid X …

Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia.

Y Wada, M Maekawa, T Ohnishi, S Balan… - Ebiomedicine, 2020 - europepmc.org
Background The pathophysiology of schizophrenia, a major psychiatric disorder, remains
elusive. In this study, the role of peroxisome proliferator-activated receptor (PPAR)/retinoid X …